Show
Sort by
-
An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology framework
-
Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC : EORTC 22113-08113 LungTech phase II trial results
-
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study
-
- Journal Article
- A1
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
-
Role of radiotherapy in the management of brain metastases of NSCLC : decision criteria in clinical routine
-
Role of postoperative radiotherapy in the management for resected NSCLC : decision criteria in clinical routine pre- and post-LungART
-
- Journal Article
- A1
- open access
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
-
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
-
- Journal Article
- A1
- open access
Practice recommendations for lung cancer radiotherapy during the covid-19 pandemic : an estro-astro consensus statement
-
Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer